Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1979 1
1983 1
1984 3
1985 1
1986 2
1987 2
1989 2
1990 2
1991 5
1992 2
1993 4
1994 2
1995 1
1996 2
1997 5
1998 1
1999 8
2000 5
2001 4
2002 6
2003 7
2004 9
2005 2
2006 3
2007 8
2008 5
2009 8
2010 4
2011 13
2012 6
2013 10
2014 14
2015 7
2016 9
2017 11
2018 6
2019 6
2020 8
2021 9
2022 10
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Rhabdomyosarcoma, embryonal, 2"
Page 1
Uterine sarcomas and rare uterine mesenchymal tumors with malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group.
Croce S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, Treilleux I, Neuville A, Arnould L, Just PA, Belda MALF, Averous G, Leroux A, Mery E, Loussouarn D, Weinbreck N, Le Guellec S, Mishellany F, Morice P, Guyon F, Genestie C. Croce S, et al. Gynecol Oncol. 2022 Nov;167(2):373-389. doi: 10.1016/j.ygyno.2022.07.031. Epub 2022 Sep 14. Gynecol Oncol. 2022. PMID: 36114030 Review.
Uterine PEComa has a specific algorithm stratifying the tumors into uncertain malignant potential and malignant tumors. Embryonal rhabdomyosarcomas of the uterine cervix are not restricted to children but can also be observed in adult women and are almost always DIC …
Uterine PEComa has a specific algorithm stratifying the tumors into uncertain malignant potential and malignant tumors. Embryonal rha …
Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma.
DeMartino J, Meister MT, Visser LL, Brok M, Groot Koerkamp MJA, Wezenaar AKL, Hiemcke-Jiwa LS, de Souza T, Merks JHM, Rios AC, Holstege FCP, Margaritis T, Drost J. DeMartino J, et al. Nat Commun. 2023 May 27;14(1):3074. doi: 10.1038/s41467-023-38886-8. Nat Commun. 2023. PMID: 37244912 Free PMC article.
Paediatric rhabdomyosarcoma (RMS) is a soft tissue malignancy of mesenchymal origin that is thought to arise as a consequence of derailed myogenic differentiation. ...In malignant RMS cells, we define transcriptional programs reflective of normal myogenic differentiation a …
Paediatric rhabdomyosarcoma (RMS) is a soft tissue malignancy of mesenchymal origin that is thought to arise as a consequence of dera …
A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study.
Spunt SL, Million L, Chi YY, Anderson J, Tian J, Hibbitts E, Coffin C, McCarville MB, Randall RL, Parham DM, Black JO, Kao SC, Hayes-Jordan A, Wolden S, Laurie F, Speights R, Kawashima E, Skapek SX, Meyer W, Pappo AS, Hawkins DS. Spunt SL, et al. Lancet Oncol. 2020 Jan;21(1):145-161. doi: 10.1016/S1470-2045(19)30672-2. Epub 2019 Nov 27. Lancet Oncol. 2020. PMID: 31786124 Free PMC article.
At a median follow-up of 6.5 years (IQR 4.9-7.9), 5-year event-free survival and overall survival were: 88.9% (95% CI 84.0-93.8) and 96.2% (93.2-99.2) in the low-risk group; 65.0% (58.2-71.8) and 79.2% (73.4-85.0) in the intermediate-risk group; …
At a median follow-up of 6.5 years (IQR 4.9-7.9), 5-year event-free survival and overall survival were: 88.9% (95% CI 84.0-93.8) and 96.2 …
Embryonal Rhabdomyosarcoma of the Uterine Cervix: A Clinicopathologic Study of 94 Cases Emphasizing Issues in Differential Diagnosis Staging, and Prognostic Factors.
Devins KM, Young RH, Ghioni M, Burandt E, Bennett JA, Oliva E. Devins KM, et al. Am J Surg Pathol. 2022 Nov 1;46(11):1477-1489. doi: 10.1097/PAS.0000000000001933. Epub 2022 Aug 9. Am J Surg Pathol. 2022. PMID: 35941719
Embryonal rhabdomyosarcoma of the uterine cervix (cERMS) is rare and frequently associated with DICER1 mutations. ...Tumor size ranged from 2 to 24 (median=4.5) cm. Ninety-two tumors were polypoid, most being grape-like (77 of 92). ...
Embryonal rhabdomyosarcoma of the uterine cervix (cERMS) is rare and frequently associated with DICER1 mutations. ...Tumor siz …
Uncovering metabolism in rhabdomyosarcoma.
Monti E, Fanzani A. Monti E, et al. Cell Cycle. 2016;15(2):184-95. doi: 10.1080/15384101.2015.1071746. Cell Cycle. 2016. PMID: 26209235 Free PMC article. Review.
Rhabdomyosarcoma (RMS) is a myogenic tumor classified as the most frequent soft tissue sarcoma affecting children and adolescents. The histopathological classification includes 5 different histotypes, with 2 most predominant referred as to embryonal and alveo …
Rhabdomyosarcoma (RMS) is a myogenic tumor classified as the most frequent soft tissue sarcoma affecting children and adolescents. Th …
Molecular diagnostics in the management of rhabdomyosarcoma.
Arnold MA, Barr FG. Arnold MA, et al. Expert Rev Mol Diagn. 2017 Feb;17(2):189-194. doi: 10.1080/14737159.2017.1275965. Epub 2017 Jan 6. Expert Rev Mol Diagn. 2017. PMID: 28058850 Free PMC article. Review.
A classification of rhabdomyosarcoma (RMS) with prognostic relevance has primarily relied on clinical features and histologic classification as either embryonal or alveolar RMS. The PAX3-FOXO1 and PAX7-FOXO1 gene fusions occur in 80% of cases with the alveolar subty …
A classification of rhabdomyosarcoma (RMS) with prognostic relevance has primarily relied on clinical features and histologic classif …
Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Allen-Rhoades W, Lupo PJ, Scheurer ME, Chi YY, Kuttesch JF, Venkatramani R, Meyer WH, Mascarenhas L. Allen-Rhoades W, et al. Cancer Med. 2023 May;12(9):10222-10229. doi: 10.1002/cam4.5749. Epub 2023 Apr 4. Cancer Med. 2023. PMID: 37016270 Free PMC article.
BACKGROUND: Patients with alveolar rhabdomyosarcoma (ARMS) have inferior outcomes compared to patients with embryonal rhabdomyosarcoma (ERMS) and more effective chemotherapy options are needed for these patients. Vinorelbine is a semisynthetic vinca alkaloid …
BACKGROUND: Patients with alveolar rhabdomyosarcoma (ARMS) have inferior outcomes compared to patients with embryonal rhabd …
Anaplasia in childhood rhabdomyosarcoma: An under reported entity.
Ahuja M, Tomar R, Thakur S, Mallya V, Mandal S, Khurana N, Sarin YK. Ahuja M, et al. Indian J Pathol Microbiol. 2022 Oct-Dec;65(4):864-868. doi: 10.4103/ijpm.ijpm_178_21. Indian J Pathol Microbiol. 2022. PMID: 36308195 Free article.
Out of 11 cases, 2 were further diagnosed as Embryonal, 2 as Alveolar, 2 as Pleomorphic, 1 as Spindle subtype and rest 4 as RMS-NOS based on morphology. ...Out of these seven, five cases showed Focal Anaplasia (FA) (71.4%) and 2 cases showed Dif …
Out of 11 cases, 2 were further diagnosed as Embryonal, 2 as Alveolar, 2 as Pleomorphic, 1 as Spindle subtype an …
Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.
Gallagher KPD, van Heerden W, Said-Al-Naief N, Carlos R, Arboleda LPA, Rodrigues-Fernandes CI, Araújo ALD, Fonseca FP, Pontes HAR, Innocentini LMAR, Romañach MJ, Vargas PA, Lopes MA, Santos-Silva AR, Khurram SA. Gallagher KPD, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Sep;134(3):354-366. doi: 10.1016/j.oooo.2021.12.128. Epub 2021 Dec 25. Oral Surg Oral Med Oral Pathol Oral Radiol. 2022. PMID: 35840496 Review.
RESULTS: HNRMS predominantly affects pediatric patients (44.4%), and the parameningeal region (57.7%) is the most common location. The alveolar variant (43.2%) predominates over the embryonal and spindle cell/sclerosing types, followed by the epithelioid and pleomor …
RESULTS: HNRMS predominantly affects pediatric patients (44.4%), and the parameningeal region (57.7%) is the most common location. The alveo …
Pediatric imaging in DICER1 syndrome.
Bueno MT, Martínez-Ríos C, la Puente Gregorio A, Ahyad RA, Villani A, Druker H, van Engelen K, Gallinger B, Aronoff L, Grant R, Malkin D, Greer MC. Bueno MT, et al. Pediatr Radiol. 2017 Sep;47(10):1292-1301. doi: 10.1007/s00247-017-3875-0. Epub 2017 May 4. Pediatr Radiol. 2017. PMID: 28474256
An imaging database search including keywords pleuropulmonary blastoma, cystic nephroma, pineoblastoma, embryonal rhabdomyosarcoma, ovarian sex cord-stromal tumor, ovarian Sertoli-Leydig cell tumor and DICER1 syndrome, was cross-referenced against the institutional …
An imaging database search including keywords pleuropulmonary blastoma, cystic nephroma, pineoblastoma, embryonal rhabdomyosarcoma …
203 results